benign%20prostatic%20hyperplasia
BENIGN PROSTATIC HYPERPLASIA
Benign prostatic hyperplasia (BPH) is a histopathological diagnosis characterized by epithelial cell & smooth muscle cell proliferation in the transition zone of the prostate leading to a non-malignant enlargement of the gland, which may result in lower urinary tract symptoms, including voiding and storage symptoms.
It is commonly called enlarged prostate.
Etiology is unknown but due to its similarity to the embryonic morphogenesis of the prostate has led to the hypothesis that BPH may be the result of "reawakening" in adulthood of embryonic induction processes.

Benign%20prostatic%20hyperplasia Patient Education

Lifestyle Modification

  • Reduce intake of liquids, particularly before going out in public or before periods of sleep
  • Avoid or reduce intake of caffeinated or alcoholic beverages and spicy foods
  • Avoid or monitor use of medications such as decongestants, antihistamines, antidepressants, and diuretics
  • Train the bladder to hold more urine for longer periods
  • Exercise pelvic floor muscles (Kegel exercise)
  • Prevent or treat constipation
  • Try to urinate at least once every 3 hours
  • “Double voiding” may help - after urinating, wait, and try to urinate again
  • Advise urethral milking to prevent postmicturition dribble
  • Try to achieve and maintain a healthy weight
Editor's Recommendations
Most Read Articles
Jairia Dela Cruz, 05 Oct 2020
Drinking more than two cups of coffee per day may just be the intervention that prevents hundreds of thousands of liver disease‐related deaths globally, a study reports.
Pearl Toh, 21 Sep 2020
Early and sustained treatments with simplified regimen are the key to achieving good asthma control, said experts during a presentation at the ERS 2020 Congress.
Roshini Claire Anthony, 12 Oct 2020

Insulin icodec, an in-development basal insulin analogue administered once weekly, was as effective as once-daily insulin glargine in patients with type 2 diabetes (T2D) insufficiently controlled with metformin with or without a DPP-4* inhibitor, according to a phase II trial presented at EASD 2020.

08 Oct 2020
Diabetes, hypertension, and older age are associated with lower hospital readmission in patients with gastroparesis, while higher length of stay (LOS), drug abuse, and marijuana use increase the 30-day readmission rate, a study has shown.